This article examines Tirzepatide’s GIPR-mediated cAMP/PKA/HSL signaling in adipocytes and the insulin-state-dependent lipolysis switch observed in preclinical metabolic models.
An examination of retatrutide’s triple GLP-1R/GIPR/GCGR agonism and the GCGR-cAMP-PKA-FOXO1 signaling axis governing PCK1 and G6PC expression in hepatic gluconeogenesis research models.
An examination of retatrutide’s triple GLP-1R/GIPR/GCGR agonism and the GCGR-cAMP-PKA-FOXO1 signaling axis governing PCK1 and G6PC expression in hepatic gluconeogenesis research models.
A research-context examination of GLP-1 receptor expression in hippocampal neurons, BDNF upregulation pathways, and the preclinical evidence on adult neurogenesis in rodent models, including key translational limitations.
A detailed scientific overview of the preclinical literature regarding Tirzepatide mechanisms.
An examination of Retatrutide’s glucagon receptor (GCGR) agonism and its proposed role in hepatic fatty acid oxidation via CPT1 disinhibition, with analysis of early-phase clinical liver-fat data and translational limitations for NAFLD research contexts.
An examination of GIPR Gs-cAMP-PKA signaling in retatrutide’s triple receptor mechanism, focusing on differential activation patterns in adipose and pancreatic tissue in preclinical models.
An examination of preclinical evidence on how retatrutide’s GLP-1R and GCGR agonism relates to arcuate nucleus appetite circuit signaling, with attention to POMC depolarization mechanisms, NPY/AgRP inhibition pathways, and the current gaps in triple-agonist hypothalamic circuit mapping.
An examination of semaglutide’s GLP-1 receptor distribution across enteroendocrine L-cells, vagal afferent neurons, and central nuclei, with focus on cAMP/PKA/EPAC2 downstream cascades and the unresolved question of peripheral versus central pathway contributions in preclinical appetite regulation models.
An examination of GIPR-specific Gs-cAMP-PKA/EPAC2 signaling in pancreatic beta cells and adipocytes, exploring differential receptor expression patterns versus GLP-1R in rodent metabolic models.